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Background: Molecular latency allows HIV-1 to persist in resting memory CD4+ T-cells as transcriptionally silent
provirus integrated into host chromosomal DNA. Multiple transcriptional regulatory mechanisms for HIV-1 latency
have been described in the context of progressive epigenetic silencing and maintenance. However, our
understanding of the determinants critical for the establishment of latency in newly infected cells is limited.
Results: In this study, we used a recently described, doubly fluorescent HIV-1 latency model to dissect the role of
proviral integration sites and cellular activation state on direct non-productive infections at the single cell level.
Proviral integration site mapping of infected Jurkat T-cells revealed that productively and non-productively infected
cells are indistinguishable in terms of genomic landmarks, surrounding epigenetic landscapes, and proviral
orientation relative to host genes. However, direct non-productive infections were inversely correlated with both
cellular activation state and NFκB activity. Furthermore, modulating NFκB with either small molecules or by
conditional overexpression of NFκB subunits was sufficient to alter the propensity of HIV-1 to directly enter a
non-productive latent state in newly infected cells. Importantly, this modulatory effect was limited to a short time
window post-infection.
Conclusions: Taken together, our data suggest that cellular activation state and NFκB activity during the time of
infection, but not the site of proviral integration, are important regulators of direct HIV-1 non-productive infections.
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Integrated HIV-1 provirus transcribes messenger and
genomic RNA to produce progeny virions. However,
the HIV-1 promoter can also exist in an inactive state,
and the subsequent lack of viral products allows la-
tently infected cells to escape both immune surveillance
and viral cytopathic effects (reviewed in [1-3]). Import-
antly, latent HIV-1 remains functional and can be reac-
tivated by cellular activation, for example. This results
in proviral transcription and production of new virions
[4]. Thus, HIV-1 latency, which allows the virus to per-
sist indefinitely during highly active antiretroviral ther-
apy (HAART), is one of the most significant barriers to
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reproduction in any medium, provided the orHIV-1 latency is generally regarded as a product of
proviral transcriptional silencing. Numerous silencing
mechanisms have been characterized using in vitro la-
tency models that require cellular activation and long-
term culturing to identify and isolate latently infected
cells. Given these requirements, the majority of known
silencing mechanisms pertain to the progressive silen-
cing of productive infections and the maintenance of a
latent state. Nevertheless, known HIV-1 transcriptional
silencing mechanisms include: 1) suboptimal T-cell acti-
vation, 2) low levels of transcriptional activator function,
3) restrictive chromatin structure at the site of integra-
tion, 4) transcriptional interference at the site of inte-
gration, 5) low pTEF-b (CDK9/Cyclin T1) levels, and
6) repressive HIV-1 LTR nucleosome positioning and
histone post-translational modifications (reviewed in
[1-3]).
Without the ability to identify latently infected cells
early, and in the absence of activation stimuli, it isral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cing mechanisms are critical for latency establishment in
newly infected cells. Thus, we and others have recently
developed double-labeled HIV-1 latency models that can
detect both productive and non-productive proviral
states early post-infection [5,6]. Application of these
models to both cell lines and activated primary CD4+
T-cells suggests that direct non-productive infections
(latency) actually represent the majority of HIV-1 infec-
tions [5,6]. This conclusion is further supported by
other studies identifying silent/inducible infections
early in infection [7,8]. Taken together, these studies
provide significant support for the role of direct silen-
cing in HIV-1 latency establishment, and highlight the
importance of studying establishment mechanisms in
newly infected cells.
In this study, we use our doubly fluorescent HIV-1 re-
porter [5] to directly evaluate potential mechanisms re-
sponsible for the formation of direct non-productive
states in newly infected Jurkat T-cells. We focus on two
highly variable HIV-1 transcriptional regulatory mecha-
nisms: 1) proviral integration site, and 2) cellular activa-
tion state and NFκB signaling. First, we show that direct
non-productive infections occur at all sites of integra-
tion, thereby excluding a role for viral integration site
locations. Instead, the occurrence of non-productive in-
fections was inversely correlated with cellular activation
state and NFκB activity. Moreover, modulating NFκB
levels at the time of infection, either by small molecules
or NFκB subunit overexpression, was sufficient to alter
the occurrence of non-productive infection in newly
infected cells. Taken together, our data suggest that the
cellular level of NFκB activity at the time of infection,
rather than the site of viral integration, controls the
establishment of HIV-1 latency in newly infected T-cell
lines. These findings are of relevance to HIV-1 eradica-
tion strategies since they may point to putative targets
for therapeutic interventions minimizing HIV-1 latency
establishment rather than latency reactivation.
Results
The doubly labeled Red-Green-HIV-1 (RGH) molecular
clone is a recently described model that enables investiga-
tion of HIV-1 transcriptional regulatory mechanisms in
newly infected, native state cells. This single-cycle vector
incorporates both an LTR-driven gag-eGFP marker, and a
CMV-driven mCherry marker in place of Nef, to allow for
identification of both productively (eGFP+mCherry+) and
non-productively (eGFP- mCherry+) infected cells at sin-
gle cell resolution (Figure 1A, [5]). We have previously
used this vector to determine that the majority of HIV-1
proviruses are directly silenced shortly after infection in
both cell lines and primary CD4+ T cells [5]. Since the
majority of HIV-1 latency mechanisms described pertainto progressive epigenetic silencing, the determinants of
direct non-productive infection remain unknown. In this
study, we sought to use the recombinant RGH model to
dissect the roles of proviral integration site and cellular ac-
tivation state in regulating direct non-productive infection
in Jurkat T-cells.
Both productive and non-productive HIV-1 proviruses are
integrated at similar locations
HIV-1 proviral integration sites are highly variable
[1-3,9,10]. In some latency models, proximity to certain
genomic features (alphoid repeats - [11], gene deserts -
[12], and very highly expressed genes [7,12]) has been
associated with proviral transcriptional silencing. How-
ever, a recent meta-analysis of integration sites found
that, in five distinct latency models using either cell-
lines or primary T-cells, these associations are not uni-
versal properties of HIV-1 latency, but rather are specific
to the models in which they were identified [13]. Import-
antly, this study highlights the importance of characteriz-
ing the effect of integration site in each individual latency
model. In this light, we sought to determine whether
proviral integration sites were different between product-
ively and non-productively RGH-infected Jurkat cells. We
sorted total RGH infected cells into non-productively in-
fected ‘red’ (eGFP- mCherry+; ~4% of total), and product-
ively infected ‘yellow’ (eGFP+mCherry+; ~2% of total)
cell populations with more than 90% purity (Figure 1B).
The ‘double negative’ population (eGFP- mCherry-) was
also sorted and analyzed since we previously estimated
that ~30% of all RGH infections result in direct repression
of both the LTR and CMV promoters [5]. To identify sites
of viral integration, genomic DNA from each population
was extracted, digested with MseI, and ligated to adapters
[14]. Nested PCR was used to amplify LTR-host chromo-
some junctions and resulting amplicons were sequenced
by 454 pyrosequencing [14]. Reads were filtered for quality
and mapped to the human genome using the INSIPID
pipeline [15].
We mapped 2,900 and 4,271 unique integration sites
in the ‘red’ and ‘yellow’ populations, respectively. Con-
sistent with our previous characterization of ‘double
negative’ RGH infected cells [5], we were also able to
map 1,195 integration sites in this population, which
represent proviruses in which both eGFP and mCherry
markers were silenced directly upon infection.
To compare the integration sites between the cell pop-
ulations, we first compared the density of integrations
(1 Mb windows) across the whole human genome. High-
resolution mapping of the integrations found within
chromosome one, as well as within the entire human
genome, revealed that in all cell populations integrations
were largely constrained to gene dense areas, and that
the integration densities in all three cell populations
Figure 1 Experimental outline for integration site mapping in newly infected cells. A: Schematic representation of Red-Green-HIV-1 (RGH) used
in this study. The virus contains a Gag fused eGFP marker under the control of the LTR promoter as well as a constitutively expressed mCherry marker
under the control of the CMVIE promoter inserted into the nef position. B: Schematic representation for isolation of productively and non-productively
infected (RGH) Jurkat cells used for integration site mapping. Total RGH infected Jurkat cells were sorted based on eGFP and mCherry expression to
greater than 90% purity four days post-infection. Genomic DNA from approximately 5 x 105 cells of each sorted cell-population was isolated and used
to map HIV-1 integration sites by 454 deep sequencing.
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integration sites and gene densities showed a highly
significant correlation for each population (Spearman
correlation, ‘double negative’, rho = 0.78; ‘red’, rho = 0.83;
‘yellow’, rho = 0.85; p < 0.001 in all cases, Figure 2B).
This preference for HIV-1 integrations in gene-rich areas
is consistent with previous reports [9,10]. Quantification
of integration density across the genome revealed similar
integration site distributions for each of the ‘double
negative’, ‘red’, and ‘yellow’ populations (Figure 2C). Ofnote, we did observe a minor but statistically significant
decrease in integration density for the ‘red’ population in
chromosome 18 (Figure 2C – p < 0.05). We also observed a
modest but statistically significant increase in integrations
into chromosomes 3 and 16, and a decrease in integrations
into chromosome 6 for the ‘double negative’ population
(Figure 2C - p < 0.05, ANOVA for number of integrations
in each chromosome, and Student’s T test for number of
'double negative' integrations compared to 'red' and 'yellow'
populations).
Figure 2 Productive and non-productive RGH infections occur at similar viral integration sites across the genome. A: Viral integration sites
were mapped by 454 pyrosequencing in RGH infected Jurkat cells sorted for eGFP and mCherry expression. Data is shown for 1,195 eGFP- mCherry-
integrations, 2,900 eGFP- mCherry+ integrations, and 4,271 eGFP+mCherry+ integrations. Integrations and gene density across 1 Mb windows are plot-
ted for chromosome one (left panel) and the entire genome (right panel). The outer track (black histogram) depicts gene density as annotated in the
UCSC hg18 reference genome, while the inner tracks (colored line plots) indicate relative numbers of viral integrations. B: Integration density is plotted
against gene density (genes per chromosome) for each sample. A linear regression line of the plotted points is shown. Samples were tested for signifi-
cance by Spearman correlation. Rho coefficients and p values are listed. C: The proportion of total integrations in each chromosome is shown for each
sorted cell population. Error bars represent standard deviations of triplicate experiments * p < 0.05 (Student’s T test).
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previously revealed genomic preferences for HIV-1 integra-
tion in terms of gene density, distance to gene boundaries
and transcriptional start sites (TSS), DNaseI hypersensitivity,
CpG density, gene expression, and GC content [9,10]. Eachof these characteristics are indicative of HIV’s preference to
integrate into nucleosome-associated DNA within the
introns of actively transcribed genes [9,10]. We used the IN-
SIPID pipeline (Bushman Lab, University of Pennsylvania)
to compare the genomic signatures of integration between
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genomic properties of integrations in each population were
consistent with previous studies [9,10], indicating that the
RGH virus integrates into host chromatin similarly to wild
type HIV-1. Importantly, the genomic signatures of the inte-
gration events in the ‘red’ population were highly similar to
those in the ‘yellow’ population, indicating that they do not
affect non-productive and productive infections (Figure 3A).
Of note, we did observe a minor , but significant decrease
in intergenic space (‘intergenic width’ – Figure 3A, p < 0.05,
Wald test), and association with highly expressed genes
(‘top ½ expr. 1 Mb Unigene’ – Figure 3A, p < 0.05, Wald
test), suggesting that integrations in the ‘red’ population
(non-productive infections) may be located in slightly less
gene dense and less expressed regions than in the ‘yellow’
population. The profile of integrations in the ‘double
negative’ population were similar to the ‘red’ and ‘yellow’
populations but the number of integrations into genes
(coding or intronic sequence and irrespective of expression)
was significantly increased (‘in gene, refSeq’ – Figure 3A,Figure 3 Productive and non-productive RGH infections are indisting
as well as proviral orientation. A: Integration sites in each of the eGFP- m
using the INSIPID heatmap tool for genomic features (Bushman Lab, Universit
depletion of each feature, respectively, relative to matched random controls o
relative to the eGFP+mCherry+ population (dashes). B: The proportion of gen
panel) integrations relative to total integrations is shown for each of the eGFP
bars represent one standard deviation between triplicate experiments. ‘ns’ nop < 0.001, Wald test; ‘gene expr. 1 Mb, Unigene’ –
Figure 3A, p < 0.05). These findings suggest that, in certain
contexts, integration into genes could repress transcription
of both the LTR and CMV promoters in the RGH provirus
(‘double negative’ population). Of note, the gene expression
profiles used in this analysis were obtained from previous
independent datasets produced with Jurkat cells [16].
We also compared the epigenetic landscape surrounding
viral integration sites in the different RGH infected popula-
tions using INSIPID’s annotated epigenetic data from inde-
pendent Jurkat and CD4+ T-cell experiments [15,17-23].
No significant differences were observed between the ‘red’
and ‘yellow’ populations (Additional file 1: Figure S1A).
Integrations in the ‘double negative’ population were,
however, significantly less frequently associated with nu-
cleosomes and histone post-translational modifications, as
compared to the ‘red’ or ‘yellow’ populations (Additional
file 1: Figure S1A). This result, and the increased associ-
ation with genes for the ‘double negative’ population
(Figure 3A), suggests some effect of integration site onuishable in terms of genomic features at the site of integration,
Cherry-, eGFP- mCherry+, and eGFP+mCherry+ samples were compared
y of Pennsylvania). Pink and blue colors represent enrichment and
f integration sites. Statistical significance (ranked Wald tests) is shown
ic (top panel), anti-parallel (bottom left panel) and parallel (bottom right
- mCherry-, eGFP- mCherry+, and eGFP+mCherry+ infected cells. Error
n-significant; * p <0.05 (Student’s T test).
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likely does not explain the transcriptional differences
between the different RGH infected populations. Moreover,
this is likely not an HIV-1 specific effect since both the LTR
and CMV promoters are silenced in the ‘double negative’
population.
In human cells, the occurrence of transcriptional
regulation-associated histone marks is often correlated with
nucleosome position relative to gene promoters and gene
bodies [17]. Therefore, we plotted RGH integration densities
as a function of both the average distance across genes and
the average distance from gene transcriptional start sites
(TSS), however we observed no differences between cell
populations in either case (Additional file 1: Figure S1B).
We next experimentally tested the effect of the epigenetic
landscape on the productivity of RGH infection by utilizing
an N74D capsid mutant that causes integration into regions
of lower gene density and increased heterochromatin
[24-26]. However, no differences were observed in the ratio
of non-productive (‘red’) to productive (‘yellow’) infections
between the RGH N74D capsid mutant and the wild-type
RGH vector, further suggesting that epigenetic profiles sur-
rounding integration sites are not major mediators of direct
non-productive infection (Additional file 1: Figure S1C).
The orientation of proviral integrations within host genes
has also been implicated in HIV-1 transcriptional regulation
and latency [27-29]. However, another study did not
observe a role for proviral orientation across multiple
latency models [13]. Therefore, we compared the frequency
of parallel and anti-parallel genic integrations between
the RGH infected cell populations. The frequency of paral-
lel and anti-parallel intragenic orientations were similar
(~40% of total integrations), and not significantly different
between cell populations (Figure 3B). Supplementary to
proviral orientation, we analyzed the nucleotide sequences
around the site of integration in RGH infected cells.
These sequences were similar between cell populations and
consistent with previously described HIV-1 target sites [9]
(Additional file 2: Figure S2A). Moreover, gene ontology
analysis did not reveal any differences in the types of genes
harboring integrated provirus between the RGH infected
cell populations (Additional file 2: Figure S2B).
Taken together, our data suggests that integration sites
fail to play a significant role in regulating direct non-
productive RGH infections in newly infected Jurkat cells.
Therefore, alternative mechanisms are likely to dictate this
process in this model T-cell system.
Direct non-productive HIV-1 infection is associated with
lower cellular activation and NFκB signaling
HIV-1 transcription is tightly linked to both cellular
activation and the activity of signaling pathways down-
stream of the T-cell receptor (reviewed in [1,3]). Moreover,
the NFκB pathway is an important and potent regulator ofHIV-1 transcription (reviewed in [30]), and has been previ-
ously implicated in mediating early productive HIV-1 infec-
tions [7]. Given that direct non-productive RGH infection
is independent of proviral integration sites (Figures 2 and 3,
S1 and S2), we speculated that differences in cellular activa-
tion state and NFκB signaling around the time of infection
could be responsible.
To analyze the effect of cellular activation on non-
productive RGH infection we measured CD69 expression,
a well characterized early T-cell activation marker [31], in
the different populations of RGH infected cells. Staining
total RGH infected cells for CD69 early post-infection (four
days) showed that the gated ‘red’ and ‘yellow’ populations
expressed approximately 2.3 and 4.5 fold more CD69 than
mock-infected cells, respectively (Figure 4A). In contrast,
the gated ‘double negative’ population (uninfected and
eGFP- mCherry- infected cells) expressed CD69 at levels
similar to the mock-infected cells (Figure 4A). Importantly,
RGH infection itself did not activate Jurkat cells, as we did
not observe substantial differences in CD69 expression
between the total RGH infected population and mock
infected cells (Additional file 3: Figure S3A). These data
suggest that differences in LTR transcription from provi-
ruses in newly infected cells are, in fact, associated with
differences in cellular activation state.
To specifically address the role of NFκB in the establish-
ment of direct non-productive infections, we infected cells
with RGH and examined NFκB levels four days post-
infection by intracellular staining for the DNA-binding p50
subunit of NFκB and the activated form of the trans-
activating p65 subunit (S529-phospho) (Figure 4B). Both
NFκB subunit levels were positively correlated with active
transcription, as the gated ‘red’ and ‘yellow’ populations
expressed approximately 1.3 and 1.5 fold more of both sub-
units, respectively, whereas the ‘double negative’ population
expressed the lowest levels of both subunits (Figure 4B). Of
note, expression of p50 and p65-S529-phospho increased
concomitantly in 'red' and 'yellow' cells, suggesting that
productive infections are associated with higher cellular
levels of the activating form of NFκB (p65-p50) rather than
the inhibitory p50-p50 form (Figure 4B). Importantly, RGH
infection does not appear to up regulate NFκB, as the total
RGH infected population and mock infected cells expressed
similar amounts of both NFκB subunits (Additional file 3:
Figure S3B).
To futher evaluate the role of NFκB signaling in promot-
ing productive infection in newly infected cells, we simul-
taneously monitored both HIV-1 transcription as well as
NFκB signaling at the single cell level. We created an RGH
isogenic clone bearing the blue fluorescent protein tagBFP
in place of eGFP (Red-Blue-HIV-1, RBH), as well as five
Jurkat NFκB reporter cell lines bearing integrated eGFP
constructs under the control of an NFκB responsive pro-
moter (Figure 4C). Infection of Jurkat cells with RBH
Figure 4 (See legend on next page.)
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Figure 4 Non-productive RGH infection inversely correlates with both cellular activation and NFκB activity. A: RGH infected Jurkat cells (four
days post-infection) were assayed for cellular activation by staining with anti-CD69 antibodies and analysis by flow cytometry. Uninfected cells were
treated with either DMSO or PMA/Ionomycin for 24 hours prior to analysis. Error bars represent standard deviations of triplicate experiments. * p < 0.05,
*** p < 0.001 (Student’s T test). B: Four days post-infection, RGH infected Jurkat cells were stained for NFκB p50 (left panel) and p65-S529-phospho
(right panel) subunits and analyzed by flow cytometry. Uninfected cells were treated with DMSO or PMA/Ionomycin for 30 min prior to analysis. Error
bars represent standard deviations of triplicate experiments. ‘ns’ non-significant, * p < 0.05, ** p < 0.01, *** p < 0.001 (Student’s T test). C: Schematic
representation of Red-Blue-HIV-1 (RBH) and NFκB-eGFP reporter cell lines. RBH contains tagBFP in place of eGFP but is otherwise isogenic. Jurkat NFκB
reporter cell lines contain a stably integrated eGFP marker driven by an NFκB responsive promoter (4x tandem NFκB cis-elements ‘GGGACTTTCC’
upstream of a CMV minimal promoter). D: Jurkat cells were infected with comparable amounts of RGH and RBH viral stocks. Cells were analyzed by
flow cytometry four days post-infection. Plots shown are representative of multiple independent infection experiments. E: Jurkat NFκB reporter clone 1
was treated with DMSO, TNFα, or PMA/Ionomycin for 24 hours prior to analysis by flow cytometry for eGFP mean fluorescence intensity (MFI). Error
bars represent one standard error of the mean. *** p < 0.001 (Student’s T test). F: Jurkat NFκB reporter clone 1 was infected with RBH and analyzed by
flow cytometry at four days post-infection. Cells were gated into their constituent infected populations and then analyzed for eGFP MFI. Error bars
represent one standard error of the mean. *** p < 0.001 (Student’s T test).
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the majority of RBH infections resulted in direct non-
productive infection (Figure 4D). Treatment of the NFκB-
eGFP reporter cell lines with known NFκB agonists
TNFα and PMA/Iono resulted in 2.2 and 3.7 fold increases
in eGFP mean fluorescence intensity (MFI), respectively
(Figure 4E, Additional file 4: Figure S4A). Infection of the
NFκB reporter cell lines with RBH virus showed that the
productively infected cells (tagBFP +mCherry+, ‘purple’)
were characterized by higher eGFP MFI (indicative of active
NFκB signaling) compared to non-productively infected
cells (tagBFP- mCherry+ ‘red’, or tagBFP- mCherry- ‘double
negative’, Figure 4F – clone 1, Additional file 4: Figure S4B
– clones 2–4). Importantly, RBH infection itself did not up
regulate NFκB, as we did not observe substantial differences
in eGFP fluorescence intensity between RBH- and mock-
infected total cells (Additional file 3: Figure S3C). These
data are consistent with the results of the intracellular NFκB
staining of RGH infected Jurkat cells, and lend further sup-
port to the role of NFκB in regulating early RGH productive
infections.
NFκB modulating drugs administered at the time of infection
can alter the occurrence of productive RGH infection
Our data indicate that cellular activation and NFκB signal-
ing may influence the occurrence of direct non-productive
infections in RGH infected cells (Figure 4). Therefore, we
hypothesized that modulating NFκB activity during infec-
tion would affect the formation of direct non-productive
infections. To test this, we treated Jurkat cells with TNFα
(NFκB signaling agonist), BMS-345541 (IκB kinase inhibi-
tor), SAHA (HDAC inhibitor) or DMSO (control) during
RGH infection. The infected cells were cultured for three
days, treated with either DMSO or PMA/Iono for 24 hours,
and then analyzed by flow cytometry.
Cells treated with the DMSO control at the time of
infection showed the typical higher frequency of non-
productively infected cells compared to productively in-
fected cells (‘red-yellow ratio’ ~1.7 – Figures 5A and B).Subsequent treatment with PMA/Iono prior to flow cy-
tometry strongly induced LTR expression, resulting in
an increase in productively infected cells (‘red-yellow
ratio’ ~0.7, Figures 5A and B). In contrast, TNFα treat-
ment at the time of infection reduced the number of
non-productively infected cells by ~2.3 fold (‘red-yellow
ratio’ ~0.7), indicating that NFκB up regulation during
infection largely mitigates the formation of direct non-
productive infection. Furthermore, TNFα treatment at
the time of infection prevented LTR transcriptional
silencing days later, as PMA/Iono treatment prior to
analysis had no further effect in reducing the proportion
of non-productively infected cells (Figures 5A and B).
TNFα treatment at the time of infection increased the
total number of both productive and non-productive in-
fections, suggesting that proviruses present in the
‘double negative population’ were shifted to productive
(‘yellow’) and non-productive (‘red’) infections (compare
DMSO to TNFα treatment, Figure 5A). Of note, similar
effects were observed with PMA/Iono pre-treatment
which, in addition to other effects, stimulates NFκB ac-
tivity in cells (data not shown). Conversely, down regula-
tion of NFκB by BMS-345541 treatment at the time of
infection resulted in a ~2.7 fold increase in the fre-
quency of non-productive infections (‘red-yellow ratio’
~4.4, Figure 5A and B). This increase in non-productive
infections was counteracted by subsequent PMA/Iono
treatment prior to flow cytometry, which increased pro-
ductive infections by ~4.1 fold (‘red-yellow ratio’ ~1.1,
Figure 5A and B). Interestingly, treatment with the
HDAC inhibitor SAHA did not mitigate the formation
of direct non-productive infection (‘red-yellow ratio ~
1.5, Figure 5A and B), despite being a known activator of
LTR transcription in other experimental settings [32,33].
This is consistent with previous reports [7], and suggests
that epigenetic modifications, such as acetylation (sensi-
tive to the HDAC1 inhibitor SAHA), are likely not a
major mediator of direct non-productive infections. In-
deed, SAHA (and HDAC inhibitors in general) modulates
Figure 5 The frequency of non-productive RGH infection can be altered by treatment of cells with NFκB modulating drugs at the time of
infection. A: Jurkat cells were treated with DMSO, TNFα, BMS-345541, or SAHA at the time of RGH infection. Four days post-infection cells were treated
with either DMSO or PMA/Ionomycin for 24 hours and analyzed by flow cytometry. Plots shown are representative of triplicate infection experiments.
B: Data from panel A is enumerated as the red-yellow ratio of infected cells. Error bars represent standard deviations of triplicate experiments. ‘ns’ non-
significant, *** p < 0.001 (Student’s T test).
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fecting T cell receptor pathways [34].
Taken together, these results suggest that direct non-
productive RGH infection is regulated by the action of
NFκB signaling at the time of infection and that the
propensity to form a non-productive infection can be
modulated by NFκB agonists (TNFα and PMA/Iono) and
antagonists (BMS-345541).Specifically modulating NFκB is sufficient to modulate the
occurrence of productive RGH infection
While the major target of TNFα signaling is NFκB, TNFα
can also affect the stress response related JNK-MAPK
pathway and its downstream factor AP-1 (reviewed in [35]).
Although TNFα-mediated reduction of RGH latency can
likely be attributed to NFκB (Figures 4 and 5), it is possible
that other pleiotropic effects may be contributing to the
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and temporal fashion, we generated Jurkat cell-lines bearing
doxycycline inducible versions of a dominant negative
(DN) form of the IκBα repressor (S32A/S36A - [36]), or the
NFκB p65 subunit to allow direct down- or up-regulation
of NFκB signaling, respectively.
We infected Jurkat cells containing the doxycycline
inducible constructs with RGH and cultured the cells in the
presence of doxycycline for 24 hours (day 1 to day 2 post-
infection). Cells were washed and cultured in fresh complete
media until flow cytometry at four and seven days
post-infection (Figure 6A). Expression of DN IκBα resulted
in a ~1.8 fold increase in the occurrence of non-productive
infections, relative to empty vector control cells (‘red-yellow
ratio’ ~3.4, Figure 6B). Of note, cells expressing the DN IκBα
construct showed a ~1.5 fold increase in non-productively
infected cells even in the absence of doxycycline (‘red-yellow
ratio’ ~2.9, Figure 6B), which suggests leaky expression of
the DN IκBα construct. In contrast to DN IκBα, cells ex-
pressing the p65 expression construct resulted in a ~2.6 foldFigure 6 Direct alteration of NFκB activity near the time of infection
infection. A. Experimental outline for doxycycline-inducible NFκB modulat
integrated, doxycycline-inducible expression construct containing either a d
RGH. Cells were cultured with or without doxycycline for 24 hours, and the
at four and seven days post-infection. Error bars represent standard deviati
*** p < 0.001 (Student’s T test). C: Immunoblot analysis of cells used in pan
to nitrocellulose membrane, and blotted with antibodies against IκBα or p6decrease in the proportion of non-productively infected
cells, relative to the empty vector control (‘red-yellow ratio’
~0.7, Figure 6B). Importantly, these changes in productively
and non-productively infected cells persisted even when
cells were cultured in the absence of doxycycline for an
additional three days (day 7 post-infection, Figure 6B). These
results suggest that modulating NFκB near the time of infec-
tion exerts a lasting effect on the establishment of direct
non-productive infections and that the observed effects are
not due to continual modulation of NFκB signaling. To
further test this, we measured IκBα and p65 levels by
immunoblotting at two, four, and seven days post infection.
Concurrent with the end of doxycycline treatment, we
observed a transient increase in IκBα and p65 protein levels
at day two post-infection (Figure 6C). This increase was
specific to cells containing the expression construct and
treated with doxycycline (Figure 6C). IκBα and p65 protein
levels decreased substantially in the absence of doxycycline
treatment four days post-infection, and returned to baseline
at seven days post-infection (Figure 6C). Importantly, cellsis sufficient to modulate the frequency of non-productive RGH
ion and RGH infection of Jurkat cells. B: Jurkat cells bearing a stably
ominant negative IκBα or p65 open reading frame were infected with
n washed and cultured in fresh media until analysis by flow cytometry
ons of triplicate experiments. ‘ns’ non-significant, * p < 0.05, ** p < 0.01,
el B. Jurkat whole cell extracts were separated by SDS-PAGE, transferred
5.
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showed a significant change in the occurrence of product-
ively and non-productively infected cells (‘red-yellow-ratio’)
seven days post-infection (Figure 6B). This further supports
the idea that modulating NFκB activity near the time of
infection alters the fate of productive RGH infection on a
permanent basis.
The determination of productive RGH infection occurs
around the time of infection
Modulating NFκB activity at the time of infection altered
the proportion of non-productive RGH infections days later
(Figures 5 and 6). Therefore, we wanted to determine the
time frame in which infection productivity is amenable to
permanent modification by TNFα treatment. We reasoned
that if a window of opportunity existed to alter the infection
productivity, treatment of cells with TNFα outside of this
window should only have transient effects on the product-
ivity of RGH infection. To test this, we infected cells with
RGH and treated them with either DMSO or TNFα at four
days post-infection rather than at the time of infection.
24 hours post TNFα treatment, a portion of cells were ana-
lyzed by flow cytometry (to check for LTR induction), while
the remaining cells were allowed to recover for another
four days. Similar to TNFα treatment at the time of
infection (Figures 5A and B), treatment with TNFα four
days post-infection was able to reactivate a large proportion
of non-productive proviruses, as demonstrated by a de-
crease in the size of the ‘red’ population, and a correspond-
ing increase in the number of ‘yellow’ cells (Figure 7A).
However, after a four day recovery, the DMSO and TNFα
treated samples were largely indistinguishable in terms of
the sizes of the ‘red’ and ‘yellow’ populations, suggesting
that TNFα treatment at day four post-infection had not
permanently altered the proportion of non-productively
infected cells (Figure 7A). This data stands in contrast to
the effect of treating cells with TNFα at the time of infec-
tion (Figures 5A and B), which suggests that the formation
of direct non-productive infection occurs during, or shortly
after, proviral integration.
To further explore the timing of RGH infection prod-
uctivity, and to minimize the confounding impact of
viral state on cellular outgrowth in a mixed population,
we repeated the TNFα-treatment-recovery experiment
with RGH infected Jurkat cells sorted into their constitu-
ent ‘double negative’, ‘red’, and ‘yellow’ subpopulations.
In each of the ‘double negative’ and ‘red’ populations,
TNFα treatment of sorted cells activated a substantial
proportion of non-productive proviruses, as reflected in
the increase in the number of ‘yellow’ cells (Figure 7B).
As expected, TNFα treatment of the ‘yellow’ population
had a minimal effect, as the majority of proviruses were
already transcriptionally active (Figure 7B). Interestingly,
when the sorted populations were left to recover for fourdays, the ‘double negative’, ‘red’, and ‘yellow’ TNFα
treated cells all became indistinguishable from their
matched DMSO treated pairs (Figure 7B). This data is
consistent with results from the bulk RGH infected cells
(Figure 7A). Of note, we did not observe major differ-
ences in the ratio of live cells (FSC/SSC) between DMSO
and TNFα treatments, suggesting that HIV-induced cell-
toxicity is not a substantial issue (data not shown).
Furthermore, these findings collectively support the idea
that non-productive RGH infection is established early
(within four days post-infection) and permanently, such
that TNFα treatment applied after the infection can
no longer permanently alter the proportion of non-
productively infected cells.
Discussion
Despite extensive knowledge of individual mechanisms of
HIV-1 transcriptional regulation, our understanding of the
critical determinants for HIV-1 latency establishment in
newly infected cells is limited. This knowledge gap is
largely due to the inability to accurately identify latently
infected cells early post-infection, and in their native state
(i.e. without inducing cellular and viral activation). To
circumvent these road-blocks, we and others have recent
developed ‘double-labeled’ HIV-1 vectors incorporating
constitutive markers of infection [5,6]. Initial studies with
these models have revealed that a large proportion of
HIV-1 infections result in a direct latent state, however
the mechanisms by which these infections form remains
unknown. In this study we used a doubly labeled HIV-1
latency model [5] to show that the cellular activation state
and NFκB activity around the time of infection, but not
viral integration site, are important for regulating direct
non-productive infections in Jurkat T-cells.
Although primary CD4+ T-cells are considered to be the
gold standard for HIV-1 latency models, we note a number
of technical issues precluding the precise and unbiased
evaluation of direct non-productive RGH infection in rest-
ing CD4+ T-cells. Nevertheless, we previously observed
that RGH infection of activated primary CD4+ T-cells
from three donors results in a high degree of direct
non-productive infection, comparable to Jurkat cells [5].
Furthermore, another group also noted a high degree of
latency in activated primary CD4+ T-cells [8]. This suggests
that activated primary CD4+ T-cell infections may be
accurately recapitulated in Jurkat cells. Thus, the results
obtained with Jurkat cells in this study are likely to hold in
primary T-cells, especially if primary cells must be activated
in order to render them permissive to infection.
Previous reports have implicated integration site variabil-
ity as a determinant for HIV-1 latency. Most notably,
latency was correlated with integration into gene deserts,
highly transcribed genes (high transcriptional interference)
and alphoid repeats [11,12,37]. However, high-throughput
Figure 7 The productivity of RGH infection is determined within four days post-infection. A: Jurkat cells were infected with RGH. Four days
post-infection, cells were treated with either DMSO or TNFα for 24 hours before analysis by flow cytometry. Cells were left to recover for four days
prior to re-analysis by flow cytometry. The percentage of cells in each of the eGFP- mCherry-, eGFP- mCherry+, and eGFP+mCherry+ quadrants is
shown in the circle plots. Data shown is representative of duplicate experiments. B: Jurkat cells were infected with RGH and sorted three days
post-infection into eGFP- mCherry-, eGFP- mCherry+, and eGFP+mCherry+ (>90% purity). After 24 hours, the sorted cells were treated with either
DMSO or TNFα for 24 hours prior to analysis by flow cytometry. Treated cells were left to recover for four days prior to further flow cytometry
analysis. Data are representative of duplicate experiments.
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tions into such regions are highly disfavored [9,10]. Instead,
most proviruses are located within actively transcribed
genes that are enriched for histone marks associated with
active chromatin (H3K4me3, lysine acetylation), and
depleted for marks associated with repressive chromatin
(H3K9me3, H3K27me3) [9,10,12,38,39]. We speculate that
latency models using cellular activation and long-termculturing to identify and establish latency could select for
the most strongly repressed latent proviruses, thereby
resulting in an over-representation of such disfavored inte-
gration locations. Our analysis of proviral locations in RGH
infected Jurkat cells shows little evidence for integration
sites regulating the difference between ‘red’ (eGFP-
mCherry+) and ‘yellow’ (eGFP+mCherry+) cells (Figures 2
and 3, S1, and S2). Furthermore we did not find any
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of integration sites. Moreover, the frequency at which these
types of integrations occur is incompatible with the degree
of direct non-productive infections observed in the RGH
model [5] and by other groups [6-8]. Our conclusions are
in agreement with a recent meta-analysis of HIV-1 integra-
tion sites in five primary and cell line latency models [13].
In this study, the authors found no genomic predictors of
latency and, interestingly, only little overlap of chromo-
somal features between latency models [13]. This highlights
the intrinsic mechanistic variability of HIV-1 latency
models, as well as the need to fully characterize determi-
nants of latency in each model.
In the absence of a role for integration sites in regulating
direct non-productive RGH infection in newly infected
Jurkat cells, the data presented in this study suggest that
productive infection is positively correlated with cellular ac-
tivation and NFκB activity (Figures 4, 5, 6, 7, and 8). Despite
this understanding, it remains to be determined what drives
fluctuations in cellular activity and corresponding NFκB
activity within any given population of newly infected cells.
In the physiological context of T-cells, the timing of infec-
tion during cellular deactivation (reversion from activated
state to memory state) is a plausible driver of activation
state heterogeneity [1]. Depending on the time of infection,
cells may be at different points in the deactivation processFigure 8 Model of NFκB mediated effects on RGH productivity
in newly infected cells. Schematic representation of productive
infection determination in RGH infected Jurkat cells. In cells with low
NFκB activity, the majority of RGH infected cells exist in a non-
productive state (eGFP- mCherry+, ‘red’) four days post infection,
whereas cells with high NFκB activity have a greater propensity to
exist in a productive state (eGFP+mCherry+, ‘yellow’) and persist
over time. TNFα stimulation of non-productively infected cells four
days post infection only temporarily reactivates HIV-1, which reverts
to its non-productive state days later.and newly integrated proviruses may be exposed to highly
variable T-cell signaling states and/or transcription factor
pools. Complementary to this, thermodynamically driven
stochastic fluctuations in cellular processes, which can drive
phenotypic asymmetry in clonal cells (reviewed in [40,41]),
may impact NFκB activity. Indeed, the NFκB and SP1 sites
of the LTR have been implicated in controlling stochastic
HIV-1 gene expression noise [42]. Other potential mecha-
nisms of NFκB fluctuation include oscillatory behavior in
response to TNFα signaling [43], and rapid nuclear shut-
tling of NFκB p65 and IκBα [44]. NFκB p65 shuttling was
shown to provide low-level basal HIV-1 transcription in in-
fected resting CD4+ T-cells [44], while shuttling of IκBα
was shown to dampen leaky NFκB signaling by removing
active NFκB p65 from the nucleus [44,45]. Taken together,
the cumulative action of several sources of fluctuation
could contribute to a wide spectrum of cellular activation
and NFκB activity in vivo. Further work is needed to eluci-
date exactly what cellular state and NFκB activity level is
deterministic for primary latency establishment.
Our data indicate that direct non-productive infections
are established around the time of infection, and that this
process is fundamentally different from latency in which
productive infections are silenced over time (Figures 5, 6, 7,
and 8). We note that treatments with NFκB agonists and
antagonists early during infection could profoundly alter
the occurrence of non-productive infection days later,
whereas treatment four days post-infection did not result in
long term modulation (Figures 7 and 8). This indicates that
once a non-productive state is established during initial in-
fection, it becomes ‘imprinted’, possibly through subsequent
epigenetic modifications (Figure 8).
Our results contribute to an emerging body of work that
links cellular activation state and transcription factor avail-
ability with the formation of HIV-1 latency. Although
evidence is mounting that NFκB contributes to latency
determination in newly infected cells (this study and [7]),
we cannot exclude the actions of other transcription factors
and/or upstream regulators in modulating latency. Most
notably, the factors SP1 [42], AP1 [46], and the Jun
N-terminal protein kinase (JNK) [47,48] have all been
implicated in HIV-1 latency. It will be of great benefit to
reconcile these studies and develop a comprehensive
understanding of how individual factors/mechanisms act
cumulatively to establish latency in newly infected cells.
Indeed, fully understanding this process is paramount to
successfully devising biologically relevant model sys-
tems suitable for screening novel latency modulating
therapeutics.
Conclusions
HIV-1 infection of Jurkat T-cells results in both productive
and non-productive proviral states shortly after infection.
Our data indicate that the differences between productive
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tion or orientation of viral integrations. Instead, the cellular
activation state and NFκB activity around the time of infec-
tion determine the outcome of viral infections and, in turn,
early latency.
Methods
Viral vectors and constructs
The Red-Green-HIV-1 (RGH) molecular clone was used as
previously described [5]. To construct the gag-N74D RGH
clone, the mutation was created by PCR mediated site
directed mutagenesis and cloning of the amplicon into the
BspQI/ApaI sites of the previously described RGH
construct [5]. The Red-Blue-HIV-1 (RBH) molecular clone
was created by cloning a synthesized tagBFP construct
(GeneWiz) into the SapI/SphI sites of RGH.
pTRIPz-EV, pTRIPz-DN-IκBα and pTRIPz-p65 are
derivatives of the commercial doxycycline-inducible lenti-
viral vector pTRIPZ-Ctrl (Thermo Fisher). pTRIPz-EV
(empty vector) was created by digestion with AgeI/
MluI, blunting with Klenow polymerase, and re-ligation.
pTRIPz-DN-IκBα contains the S32A/S36A mutant ver-
sion of the IκBα repressor PCR amplified from pSVK3-
IKBα-2N [36], which was cloned into the AgeI/MluI sites
of pTRIPz-Ctrl. pTRIPz-p65 contains a PCR amplified
NFκB p65 open reading frame cloned into the AgeI/MluI
sites of pTRIPz-Ctrl.
Cell culture, virion production, and transduction
Jurkat E6-1 [49], HEK293T (ATCC), and derivative cell
lines created in this study were cultured as previously de-
scribed [5]. VSV-G pseudotyped viral stocks were created
by transfecting HEK293T cells with envelope deleted viral
molecular clones and pHEF-VSVg [50] in a 10:1 ratio as
previously described [5]. Unless otherwise indicated,
Jurkat E6-1 cells were spinoculated as previously described
[5]. Briefly, 5 ×105 cells in 1 mL culture media (+ 4 μg/mL
polybrene) were spin-infected (1.5 hr, 500 × g, room
temperature) with 25 μL of viral stock, so as to yield an
average infection rate of than 10-15% and ensure single-
copy integrations.
NFκB-eGFP viral stocks were produced in HEK293T cells
by co-transfecting pGreenFire1-NF-κB (Systems Biosci-
ences), pHEF-VSVg [50], pLP1-gag/pol, pLP2-Rev, and
pcDNA3.1+-Tat (2 μg each, 30 μg polyethylenimine
reagent). Purified and concentrated viral stocks were
prepared as previously described [5]. NFκB reporter cell
lines were created by transducing Jurkat cells with
NFκB-eGFP virus (MOI ~ 4), followed by puromycin
selection (1 μg/mL - Clontech). Resistant cells were sub-
sequently maintained in complete media supplemented
with 0.5 μg/mL puromycin.
pTRIPz viral stocks and stable cell lines were produced
as described above for NFκB-eGFP, except that the lentiviralvectors pTRIPz-EV, pTRIPz-DN-IκBα or pTRIPz-p65
were used.
Flow cytometry and staining
Analysis of infected cells by flow cytometry and live cell
sorting were performed as previously described [5]. Of
note, in all experiments, analysis was limited to live cells
by FSC/SSC gating at the time of data acquisition. Un-
less otherwise stated, infected cells were analyzed four
days post-infection. Jurkat E6-1 cells were stained and
analyzed for CD69 as previously described [51] except
that antibodies were conjugated to PE-Cy7 and 1 μL of
antibody was used per 1 × 105 cells (BD Biosciences).
Jurkat cells were stained with PE-Cy7-NFκB p65 (pS529)
(BD Biosciences) and NFκB p50 (Abcam) with Pacific
Blue conjugated secondary antibody (Life Technologies)
as previously described [52].
Compound treatments
Infected cells were treated with the various compounds
for the times and durations indicated in individual
experiments. Compounds were added at the listed con-
centrations to complete media. Unless otherwise stated,
compounds were used at the following concentrations:
TNFα, 10 ng/mL (Sigma); SAHA, 0.5 μM [53]; PMA,
4 ng/mL (Sigma); Ionomycin, 1 μM (Sigma), BMS-
345541, 5 μM (Sigma).
Pyrosequencing of integration sites
HIV-1 integration sites were analyzed by 454 deep-
sequencing as previously described [14]. Briefly, Jurkat
cells were infected with RGH and sorted into constituent
populations three days post-infection (eGFP- mCherry-,
eGFP- mCherry+, eGFP+mCherry+). Genomic DNA was
extracted from ~ 5×105 cells of each population, digested
with MseI and ligated to adaptors. Nested PCR with
adapter and LTR specific primers was performed to
amplify the HIV-host genome junctions. After gel extrac-
tion of 100–600 bp fragments, amplicons were subjected
to pyrosequencing on a 454 GS Junior machine (Roche). Data
was analyzed using the Integration Site Pipeline and Database
(INSIPID) web tool (Bushman Lab - http://microb215.
med.upenn.edu/Insipid/ - [10,15], Circos [54], SeqMonk
software (http://www.bioinformatics.babraham.ac.uk/projects/
seqmonk/), WebLogo3 (http://weblogo.threeplusone.com/




RGH infected Jurkat cells were lysed in NP-40 lysis
buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1% (v/v)
NP-40, 0.1% (w/v) SDS) supplemented with 1x protease
inhibitor cocktail (Roche). Lysates were cleared by
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SDS-PAGE sample buffer, and boiled for 5 min. Whole
cell extracts (40 μg) were separated on a 12% SDS-PAGE
gel and then transferred to nitrocellulose membrane.
Membranes were blocked with 2% (w/v) BSA in PBS-
Tween (0.05% v/v) and then incubated with primary
antibody overnight at 4°C. Antibodies used were as
follows: IκBα – Abcam 32518 [1:5000], NFκB p65 –
Abcam 7970 [1:500], GAPDH – Abcam 9484 [1:4000].
After washing and incubation with HRP conjugated
secondary antibody, membranes were washed and signal
was developed with SuperSignal West Femto chemi-
luminescent substrate (Thermo Fisher).
Statistical analysis
Unless otherwise stated, experiments were performed in
biological triplicate. Where appropriate, statistical infer-
ence was performed on quantitative data. Two group
testing was performed using the Student’s T-test, while
comparison between multiple groups was made using
one-way-ANOVA followed by pairwise two-group
testing (Student’s T-test). Statistical analysis was per-
formed in R 2.15.1 (http://www.r-project.org/). Integration
site analysis heatmaps were created using the INSIPID
pipeline (Figures 3A and Additional file 1: Figure S1B) util-
izing previously described statistical methodology [10,15].
Briefly, for each identified integration site, matched
random controls were created in silico. This pairing of
experimental and control sites allows for computation
of relative enrichment and de-enrichment profiles using
a receiver operating characteristic framework. Compari-
sons between sets of integration sites (samples) for
statistical significance are performed by calculating
Wald-type test statistics, which are then tested using
Chi Square methods.
Additional files
Additional file 1: Figure S1. Productive and non-productive RGH
infections occur regardless of epigenetic properties at sites of integration
A: Epigenetic properties of identified integration sites were compared
between samples using the INSIPID heatmap tool for epigenetic features
(Bushman Lab, University of Pennsylvania). Included features were limited
to those identified in high-throughput studies of Jurkat and primary
CD4+ T-cells. Yellow and blue colors represent depletion and enrichment
of each feature, respectively, relative to matched random controls of
integration sites. Statistical significance (ranked Wald tests) is shown
relative to the eGFP+ mCherry+ population (dashes). B: Proviral
integrations across the entire human genome are plotted as a function
of the average distance across gene bodies (5’ to 3’ – top panel), and the
average distance from gene transcriptional start sites (TSS – bottom
panel). Data are plotted as pale filled circles with darker smoothed lines
(Loess) overlaid. C: Jurkat cells were infected with equal amounts of wild-
type RGH or an RGH version containing an N74D mutation in Capsid.
Cells were analyzed by flow cytometry four days post-infection. Represen-
tative plots (left) and graphical quantitation (right) are shown. Error bars
represent standard deviations of triplicate experiments. ‘ns’ non-
significant.Additional file 2: Figure S2. Productive and non-productive RGH
infections occur regardless of DNA sequence at the point of integration,
or functional annotation of host genes. A: Weblogo3 analysis of the DNA
sequence (+/− 20 bp) surrounding each integration site in the
eGFP- mCherry- (‘double negative’), eGFP- mCherry+ (‘red’), and eGFP+
mCherry+ (‘yellow’) populations. B: Gene ontology analysis of integration
sites in the eGFP- mCherry- (‘double negative’), eGFP- mCherry+ (‘red’),
and eGFP+mCherry+ (‘yellow’) populations, using goProfiles.
Additional file 3: Figure S3. RGH infection does not induce cellular
activation or NFκB signaling. A. Mock- and total-RGH-infected Jurkat
cells were stained for CD69 four days post-infection. Data shown is
representative of triplicate experiments. B. Mock- and total-RGH-infected
Jurkat cells were stained for either NFκB p50 or NFκB p65-S529phospho
four days post-infection. Data shown is representative of triplicate
experiments. C. Mock- and total-RBH-infected Jurkat NFkB-eGFP reporter
cell lines 1–5 were analyzed by flow cytometry four days post-infection.
Data shown is representative of multiple experiments.
Additional file 4: Figure S4. Characterization of RBH infection and
Jurkat NFκB reporter cell lines. A: Jurkat NFκB reporter clones 2–5 were
treated with DMSO, TNFα, or PMA/Ionomycin for 24 hours prior to
analysis by flow cytometry for eGFP mean fluorescence intensity (MFI).
Error bars represent one standard error of the mean. B: Jurkat NFκB
reporter clones 2–5 were infected with RBH viral stock and analyzed by
flow cytometry at four days post-infection. Cells were gated into their
constituent infected populations and then analyzed for eGFP MFI. Error
bars represent one standard error of the mean.
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